The BRI Blog

For recent medical community news and insights, engage with our recent posts below.

Drug price controls don’t simply make medicine more affordable. Rather, the heavy hand of government stifles medical innovation and weakens one’s biopharmaceutical sector—as countless other nations have proven.

Read More

A recent trade deal between the U.S. and the U.K. proves how the government can ensure other countries pick up a greater share of the global drug-development without imposing state-mandated price controls.

Read More

There’s a reason Medi-Cal’s finances are in disarray, and it’s not because the rich aren’t paying their fair share.

Read More

A competitive drug market strongly encourages companies to best their rivals by developing the next generation of life-saving therapies. This leads to lower prices without the harmful effects of government coercion.

Read More

If the government is going to spend enormous sums subsidizing health insurance, much better to give those funds to individuals and let them use the money to buy coverage of their choosing — or even pay for care directly.

Read More

The astounding expansion of Medicaid has made it harder for genuinely destitute people to get care.  That problem is only exacerbated when states flout federal laws to bring a growing number of illegal immigrants onto Medicaid’s rolls.

Read More